{"transactions":[{"id":673161,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T17:05:23.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to correct an administrative calculation error in Column 4 of Table I of the original filing relating to a grant of restricted stock units (\"RSUs\") to the Reporting Person, which resulted in the number of securities acquired by the Reporting Person being overstated. The original filing incorrectly reported 21,800 shares; the correct amount of shares acquired is 18,400. As a result of this correction, the total amount of securities beneficially owned following the reported transaction in Column 5 has been updated to 29,195. One-third of the shares subject to the RSU vest on each of July 9, 2027, July 9, 2028 and July 9, 2029, subject to the Reporting Person's continued service with the Issuer through each such vest date."}],"balance_after":29195,"source":{"system":"sec-edgar","filing":"0002059447-26-000006","document":"form4a-08282026_090818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000205944726000006/form4a-08282026_090818.xml","form_type":"4/A","original_submission_date":"2026-07-10"}},{"id":711346,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T19:36:10.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings held after the transaction reflects a 1-for-30 reverse split of the issuer's stock effected on April 22, 2026."}],"balance_after":32595,"source":{"system":"sec-edgar","filing":"0002059447-26-000004","document":"form4-07102026_110706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000205944726000004/form4-07102026_110706.xml","form_type":"4"}},{"id":947424,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T16:00:03.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":0.34,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0001193125-26-004354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526004354/ownership.xml","form_type":"4"}},{"id":955423,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T16:00:03.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":77417,"price":0.3016,"value":23348.9672,"ownership":{"direct":true},"balance_after":323857,"source":{"system":"sec-edgar","filing":"0001193125-26-000900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526000900/ownership.xml","form_type":"4"}},{"id":955422,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T16:00:03.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":78116,"price":0.3114,"value":24325.3224,"ownership":{"direct":true},"balance_after":246440,"source":{"system":"sec-edgar","filing":"0001193125-26-000900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526000900/ownership.xml","form_type":"4"}},{"id":955421,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T16:00:03.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":86947,"price":0.3174,"value":27596.9778,"ownership":{"direct":true},"balance_after":168324,"source":{"system":"sec-edgar","filing":"0001193125-26-000900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526000900/ownership.xml","form_type":"4"}},{"id":955420,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T16:00:03.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":77148,"price":0.3003,"value":23167.5444,"ownership":{"direct":true},"balance_after":81377,"source":{"system":"sec-edgar","filing":"0001193125-26-000900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526000900/ownership.xml","form_type":"4"}},{"id":955419,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T16:00:03.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":4229,"price":0.3094,"value":1308.4526,"ownership":{"direct":true},"balance_after":4229,"source":{"system":"sec-edgar","filing":"0001193125-26-000900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000119312526000900/ownership.xml","form_type":"4"}},{"id":1210262,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":18808,"kind":"person","name":"Sarraf Pasha","position":1,"cik":"0002059447","reported_name":"Sarraf Pasha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-12T16:00:05.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 10, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly\ninstallments."}],"balance_after":48800,"derivative":{"exercise_price":1.03,"expiration_date":"2035-03-09","underlying":"Common Stock","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0000950170-25-037889","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059447/000095017025037889/ownership.xml","form_type":"4"}}]}